SPDR S&P Biotech ETF $XBI Shares Acquired by Ping Capital Management Inc.

Ping Capital Management Inc. increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.3% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,000 shares of the exchange traded fund’s stock after purchasing an additional 300 shares during the period. Ping Capital Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $498,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Investment Partners Asset Management Inc. boosted its stake in SPDR S&P Biotech ETF by 4.0% in the second quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock valued at $270,000 after acquiring an additional 125 shares during the period. Compass Ion Advisors LLC boosted its stake in SPDR S&P Biotech ETF by 3.9% in the second quarter. Compass Ion Advisors LLC now owns 3,727 shares of the exchange traded fund’s stock valued at $309,000 after acquiring an additional 140 shares during the period. McAdam LLC boosted its stake in SPDR S&P Biotech ETF by 5.1% in the second quarter. McAdam LLC now owns 3,273 shares of the exchange traded fund’s stock valued at $271,000 after acquiring an additional 159 shares during the period. First Heartland Consultants Inc. boosted its stake in SPDR S&P Biotech ETF by 2.7% in the first quarter. First Heartland Consultants Inc. now owns 6,344 shares of the exchange traded fund’s stock valued at $514,000 after acquiring an additional 168 shares during the period. Finally, Calton & Associates Inc. boosted its stake in SPDR S&P Biotech ETF by 3.2% in the first quarter. Calton & Associates Inc. now owns 5,662 shares of the exchange traded fund’s stock valued at $459,000 after acquiring an additional 175 shares during the period.

SPDR S&P Biotech ETF Stock Up 1.2%

Shares of XBI stock opened at $102.59 on Friday. The business has a 50 day moving average of $91.78 and a two-hundred day moving average of $85.05. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $105.47. The company has a market cap of $5.85 billion, a P/E ratio of 11.47 and a beta of 0.97.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.